ScheldWM, SandeMA. Endocarditis and intravascular infections. In: MandellGL, BennettJE, DolinR, eds. Principles and practice of infectious diseases.New York: John Wiley and Sons Inc.,1995: 740–83.
2.
LevineDP, CraneLR, ZervosMJ. Bacteremia in narcotic addicts at the Detroit Medical Center: II. Infectious endocarditis: a prospective comparative study.Rev Infect Dis1986; 8: 374–96.
3.
CarbonC, CrémieuxAC, FantinB. Pharmacokinetic and pharmacodynamic aspects of therapy of experimental endocarditis.Infect Dis Clin North Am1993; 7: 37–51.
4.
DurakDT, BeesonPB. Experimental bacterial endocarditis: II. Survival of bacteria in endocardial vegetations.Br J Exp Pathol1972; 53: 50–3.
ChambersHF. Short-course combination and oral therapies of Staphylococcus aureus endocarditis.Infect Dis Clin North Am1993; 7: 69–80.
7.
BisnoAL, DismukesWE, DurakDT, KaplanEL, KarchmerAW, KayeD. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci.JAMA1989; 261: 1471–7.
8.
ChettyS, MithaAS. High-dose oral amoxycillin in the treatment of infective endocarditis.S Afr Med J1988; 73: 709–10.
9.
GrayJR. Management of infective endocarditis.J R Coll Physicians Lond1981; 15: 173–8.
10.
PhillipsB, WatsonGH. Oral treatment of subacute bacterial endocarditis in children.Arch Dis Child1977; 52: 235–7.
11.
PinchasA, LessingJ, SiegmanIY, LironM. Oral treatment of bacterial endocarditis.Isr J Med Sci1983; 19: 646–8.
12.
StamboulianD, BonvehiP, ArevaloC, BolognaR, CassettiI, ScilingoV. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci.Rev Infect Dis1991; 13(suppl): S160–3.
13.
ChambersHF, KorezeniowskiOM, SandeMA. Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts.Medicine (Baltimore)1983; 62: 170–7.
14.
ParkerRH, FossieckBE. Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis.Ann Intern Med1980; 93: 832–4.
15.
DworkinRJ, LeeBL, SandeMA, ChambersHF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.Lancet1989; 2: 1071–3.
16.
RoderBL, GutschikE. In vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.J Antimicrob Chemother1989; 23: 347–52.
17.
KaatzGW, SeoSM, BarriereSL, AlbrechtLM, RybakMJ. Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis.Antimicrob Agents Chemother1989; 33: 1184–7.
18.
TebasP, MartinezRR, RomanF, MendazaP, DiazJCR, DazaR. Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis.J Infect Dis1991; 163: 204–5.
19.
BabinchakTJ. Oral ciprofloxacin therapy for prosthetic valve endocarditis due to Actinobacillus actinomycetem-comitans.Clin Infect Dis1995; 21: 1517–8.
20.
UzunO, AkalinHE, UnalS, DemerircinM, YorganciogluC, UgurluB. Long-term oral ciprofloxacin in the treatment of prosthetic valve endocarditis due to Pseudomonas aeruginosa.Scand J Infect Dis1992; 24: 797–800.
21.
SacherHL, MillerWC, LandauSW, SacherM, DixonWA, DietrichKA. Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy.J Clin Pharmacol1991; 31: 719–21.